semaglutide and wegovy Wegovy® (Semaglutide) Weight Loss Injections – Dr Zohal Aesthetics Getting Started on Wegovy® for

The American Diabetes Association (ADA) guidelines recommend GLP-1 receptor agonists as preferred agents for patients with type 2 diabetes who have established atherosclerotic cardiovascular disease or indicators of high cardiovascular risk, or for those requiring additional glucose-lowering beyond metformin

Although initially approved for adults with type 2 diabetes, Ozempic has demonstrated additional benefits in weight loss and reducing cardiovascular risks

If these symptoms are minimal, you may increase the dosage slightly within the first four weeks

doi: 10.3389/fmicb.2019.02646 161 ZhouX

FCS: I think a lot of the choice may have to do with whats covered by insurance